GlaxoSmithKline
GSK
#212
Rank
ยฃ72.80 B
Marketcap
ยฃ36.04
Share price
1.69%
Change (1 day)
32.01%
Change (1 year)

Revenue for GlaxoSmithKline (GSK)

Revenue in 2025 (TTM): ยฃ32.16 Billion

According to GlaxoSmithKline's latest financial reports the company's current revenue (TTM ) is ยฃ31.75 Billion. In 2024 the company made a revenue of ยฃ31.37 Billion an increase over the revenue in the year 2023 that were of ยฃ30.32 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for GlaxoSmithKline from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ32.16 B2.52%
2024 ยฃ31.37 B3.46%
2023 ยฃ30.32 B3.42%
2022 ยฃ29.32 B-0.29%
2021 ยฃ29.41 B-13.75%
2020 ยฃ34.09 B1.02%
2019 ยฃ33.75 B9.52%
2018 ยฃ30.82 B2.1%
2017 ยฃ30.18 B8.24%
2016 ยฃ27.88 B16.58%
2015 ยฃ23.92 B3.99%
2014 ยฃ23.00 B-13.2%
2013 ยฃ26.50 B0.28%
2012 ยฃ26.43 B-3.49%
2011 ยฃ27.38 B-3.54%
2010 ยฃ28.39 B0.08%
2009 ยฃ28.36 B16.49%
2008 ยฃ24.35 B7.1%
2007 ยฃ22.73 B-2.05%
2006 ยฃ23.21 B7.23%
2005 ยฃ21.64 B6.37%
2004 ยฃ20.35 B-4.96%
2003 ยฃ21.41 B0.95%
2002 ยฃ21.21 B3.3%
2001 ยฃ20.53 B13.58%
2000 ยฃ18.07 B108.39%
1999 ยฃ8.67 B8.65%
1998 ยฃ7.98 B1.08%
1997 ยฃ7.89 B-21.56%
1996 ยฃ10.07 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AstraZeneca
AZN
ยฃ43.58 B 37.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ47.07 B 48.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.16 B 51.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ42.26 B 33.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ35.63 B 12.21%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
ยฃ12.57 B-60.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
ยฃ0.24 B-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA